1. Home
  2. ELA vs BWAY Comparison

ELA vs BWAY Comparison

Compare ELA & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envela Corporation

ELA

Envela Corporation

N/A

Current Price

$12.62

Market Cap

332.6M

ML Signal

N/A

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

N/A

Current Price

$19.28

Market Cap

337.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELA
BWAY
Founded
1965
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Consumer Specialties
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
332.6M
337.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
ELA
BWAY
Price
$12.62
$19.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$11.50
$23.50
AVG Volume (30 Days)
100.3K
67.9K
Earning Date
11-05-2025
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
58.79
213.09
EPS
0.39
0.13
Revenue
$208,843,961.00
$49,094,000.00
Revenue This Year
$19.13
$330.76
Revenue Next Year
$2.46
$22.24
P/E Ratio
$32.14
$59.95
Revenue Growth
23.18
27.08
52 Week Low
$5.10
$7.84
52 Week High
$15.09
$19.80

Technical Indicators

Market Signals
Indicator
ELA
BWAY
Relative Strength Index (RSI) 53.90 63.66
Support Level $12.33 $18.31
Resistance Level $13.00 $19.80
Average True Range (ATR) 0.84 0.80
MACD -0.15 0.15
Stochastic Oscillator 30.86 84.33

Price Performance

Historical Comparison
ELA
BWAY

About ELA Envela Corporation

Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: